financetom
Business
financetom
/
Business
/
Kyverna Therapeutics Q1 Loss Narrows
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
Kyverna Therapeutics Q1 Loss Narrows
May 14, 2024 2:25 PM

05:09 PM EDT, 05/14/2024 (MT Newswires) -- Kyverna Therapeutics ( KYTX ) reported a Q1 net loss late Tuesday of $1.12 per diluted share, compared with a loss of $12.10 per share a year earlier.

A single analyst polled by Capital IQ expected a loss of $0.80.

No revenue was reported for the quarter ended March 31, as expected for the clinical-stage drugmaker.

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
BioAtla Agrees to $22.5 Million in Financing Agreements
BioAtla Agrees to $22.5 Million in Financing Agreements
Nov 21, 2025
03:42 AM EST, 11/21/2025 (MT Newswires) -- BioAtla ( BCAB ) said Friday it entered prepaid advance and standby equity purchase agreements that provide access to up to $22.5 million in financing. The prepaid advance totals $7.5 million of face value with roughly $7.1 million gross proceeds, the company said. The advance carries 4% interest and can be repaid in...
Gloo Holdings Insider Bought Shares Worth $1,000,000, According to a Recent SEC Filing
Gloo Holdings Insider Bought Shares Worth $1,000,000, According to a Recent SEC Filing
Nov 21, 2025
03:44 AM EST, 11/21/2025 (MT Newswires) -- Patrick P Gelsinger, Director, Executive Chair and Head of Technology, on November 20, 2025, executed a purchase for 125,000 shares in Gloo Holdings ( GLOO ) for $1,000,000. Following the Form 4 filing with the SEC, Gelsinger has control over a total of 125,000 Class A common shares of the company, with 125,000...
Gloo Holdings Insider Bought Shares Worth $2,000,000, According to a Recent SEC Filing
Gloo Holdings Insider Bought Shares Worth $2,000,000, According to a Recent SEC Filing
Nov 21, 2025
03:42 AM EST, 11/21/2025 (MT Newswires) -- Jack D Furst, Director, on November 20, 2025, executed a purchase for 250,000 shares in Gloo Holdings ( GLOO ) for $2,000,000. Following the Form 4 filing with the SEC, Furst has control over a total of 275,000 Class A common shares of the company, with 275,000 shares held directly. SEC Filing: https://www.sec.gov/Archives/edgar/data/2069785/000106210325000006/xslF345X05/form4-11202025_111110.xml...
Frontline Q3 Adjusted Earnings, Revenue Fall
Frontline Q3 Adjusted Earnings, Revenue Fall
Nov 21, 2025
03:43 AM EST, 11/21/2025 (MT Newswires) -- Frontline ( FRO ) reported Q3 adjusted earnings Friday of $0.19 per share, down from $0.34 a year earlier. Analysts polled by FactSet expected $0.25. Total revenue and other operating income for the quarter ended Sept. 30 were $438.6 million, down from $490.4 million a year earlier. Shares of the company were down...
Copyright 2023-2026 - www.financetom.com All Rights Reserved